Action - AXN

Aoxing Pharmaceutical Company New (delisted) (AXN) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

0,1218

( - )

Prix Achat

Prix Vente

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

0,1218

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265%

Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265% Direct-To-Customer Sales Program Helps Raise Gross Margins To 79% PR...

Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer

Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer PR Newswire FOSTER CITY, Calif., Feb. 1, 2016 FOSTER CITY, Calif., Feb. 1, 2016...

Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of Shanghai

Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of Shanghai PR Newswire JERSEY CITY, N.J., Dec. 10, 2015 JERSEY...

Aoxing Pharma Announces Opening Of Government Funded Drug Research Center

Aoxing Pharma Announces Opening Of Government Funded Drug Research Center PR Newswire JERSEY CITY, N.J., Dec. 4, 2015 JERSEY CITY, N.J., Dec. 4...

Aoxing Pharma Announces Resignation of CFO

Aoxing Pharma Announces Resignation of CFO PR Newswire JERSEY CITY, N.J., Dec. 4, 2015 JERSEY CITY, N.J., Dec. 4, 2015 /PRNewswire/ -- Aoxing...

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aoxing Pharmaceutical Company, Inc.

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aoxing Pharmaceutical Company, Inc. PR Newswire NEW YORK...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aoxing Pharmaceutical, Inc. - AXN

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aoxing Pharmaceutical, Inc. - AXN PR Newswire NEW YORK, Dec...

Aoxing Pharmaceuticals Q1 Revenue Up 92 Percent; Net Income Of $1.35 Million

Aoxing Pharmaceuticals Q1 Revenue Up 92 Percent; Net Income Of $1.35 Million Direct-To-Customer Sales Program Helps Raise Gross Margin To 80...

Drug Manufacturers - Major Stocks on the Move -- GlaxoSmithKline, Sanofi, Aerie Pharma, TherapeuticsMD, and Aoxing Pharma

Drug Manufacturers - Major Stocks on the Move -- GlaxoSmithKline, Sanofi, Aerie Pharma, TherapeuticsMD, and Aoxing Pharma PR Newswire NEW YORK...

Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year

Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year PR Newswire JERSEY CITY, N.J., May 15, 2013...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

AXN - Frequently Asked Questions (FAQ)

What is the current Aoxing Pharmaceutical Company New (delisted) share price?

The current share price of Aoxing Pharmaceutical Company New (delisted) is US$ 0,1218

What is the 1 year trading range for Aoxing Pharmaceutical Company New (delisted) share price?

Aoxing Pharmaceutical Company New (delisted) has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aoxing Pharmaceutical Company New (delisted) (AXN)

Aoxing Pharmaceutical Company New (delisted) (AXN) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

AXN Dernières nouvelles

Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265%

Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer

Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of Shanghai

Aoxing Pharma Announces Opening Of Government Funded Drug Research Center

Aoxing Pharma Announces Resignation of CFO

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aoxing Pharmaceutical Company, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aoxing Pharmaceutical, Inc. - AXN

Aoxing Pharmaceuticals Q1 Revenue Up 92 Percent; Net Income Of $1.35 Million

Drug Manufacturers - Major Stocks on the Move -- GlaxoSmithKline, Sanofi, Aerie Pharma, TherapeuticsMD, and Aoxing Pharma

Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year

AXN - Frequently Asked Questions (FAQ)

AXN Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aoxing Pharmaceutical Company New (delisted) (AXN)

Aoxing Pharmaceutical Company New (delisted) (AXN) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

AXN Dernières nouvelles

Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265%

Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer

Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of Shanghai

Aoxing Pharma Announces Opening Of Government Funded Drug Research Center

Aoxing Pharma Announces Resignation of CFO

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aoxing Pharmaceutical Company, Inc.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aoxing Pharmaceutical, Inc. - AXN

Aoxing Pharmaceuticals Q1 Revenue Up 92 Percent; Net Income Of $1.35 Million

Drug Manufacturers - Major Stocks on the Move -- GlaxoSmithKline, Sanofi, Aerie Pharma, TherapeuticsMD, and Aoxing Pharma

Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year

AXN - Frequently Asked Questions (FAQ)

AXN Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE